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Abstract
Background: Cognitive impairment is a common feature in multiple sclerosis (MS) patients and
occurs in 60% of all cases. Unfortunately, neurological examination does not always agree with the
neuropsychological evaluation in determining the cognitive profile of the patient. On the other
hand, psychophysiological techniques such as event-related potentials (ERPs) can help in evaluating
cognitive impairment in different pathologies.
Behavioural responses and EEG signals were recorded during the experiment in three experimental
groups: 1) a relapsing-remitting group (RRMS), 2) a benign multiple sclerosis group (BMS) and 3) a
Control group. The paradigm employed was a spatial attention task with central cues (Posner
experiment). The main aim was to observe the differences in the performance (behavioural
variables) and in the latency and amplitude of the ERP components among these groups.
Results: Our data indicate that both MS groups showed poorer task performance (longer reaction
times and lower percentage of correct responses), a latency delay for the N1 and P300 component,
and a different amplitude for the frontal N1. Moreover, the deficit in the BMS group, indexed by
behavioural and pyschophysiological variables, was more pronounced compared to the RRMS group.
Conclusion: The present results suggest a cognitive impairment in the information processing in
all of these patients. Comparing both pathological groups, cognitive impairment was more
accentuated in the BMS group compared to the RMSS group. This suggests a silent deterioration
of cognitive skills for the BMS that is not usually treated with pharmacological or
neuropsychological therapy.
Background
Multiple sclerosis (MS) is a neurodegenerative disease of
the Central Nervous System (CNS) in which early symp-
toms can appear in young adults between 20 and 40 years
old. This condition damages the myelin shield of neurons
in the brain, spinal cord and optical nerves. As a conse-
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impairments that produce physical disabilities [1,2].
Most MS patients present a clinical course in which exac-
erbations and remissions occur (85–90%). If this pattern
is established, MS is classified as MS relapsing-remitting
form (RRMS). After 10 years suffering this form of the dis-
ease, 50% of patients enter in a progressive phase of the
illness defined as Secondary Progressive. The Primary Pro-
gressive form is characterized by a continuous progression
from the very beginning, without signs of remission. A
reduced number of patients present a progressive clinical
course and some of them can present bursts (Progressive-
Relapsing form). Finally, a 20% of patients show a benign
course (BMS) of the clinical condition (see [1-6] for
reviews).
The cognitive deterioration is highly prevalent as one of
the symptoms accompanying the general deterioration of
patients [7-9]. The more common functions usually
impaired are sustained attention, speed processing,
abstract reasoning, verbal fluency and visuo-spatial per-
ception among others. The cognitive deterioration pattern
must be somehow associated with the anatomopathol-
ogy, number and location of lesions, producing then a
high individual variability. However, it is difficult to
directly associate the neurological and neuropsychologi-
cal results [10,11], and the lack of correspondence
between Magnetic Resonance Imaging (MRI) character-
ised lesions and cognitive deterioration occurs very fre-
quently.
This discrepancy between cognitive-behavioural function-
ing and MRI signs has promoted the use of other tech-
niques from neuroscience disciplines to objectively
explore the relation between brain dysfunctions and neu-
ropsychological deterioration. One of these techniques is
the Event-Related-Potentials (ERPs). The endogenous
components of ERPs are particularly linked to the cogni-
tive associated symptoms of the MS condition [12,13].
The reliability of ERPs results is in the same order to those
obtained in laboratory tests [14]. Moreover, the temporal
resolution of this technique is much better than other
metabolic techniques as positron emission tomography
or functional MRI. The P300 component is being used
regularly in clinical practice [14]. Latency and amplitude
of P300 are sensitive to neural degenerative conditions as
several types of dementias and psychiatric diseases [15-
19]. The current analytical tools applied to the electroen-
cephalogram (EEG) allow to temporally and spatially
localize certain phases of cognitive processing [20]. EEG
techniques as ERPs, quantitative spectral EEG and coher-
ence analysis have shown that the EEG is modified in MS
with respect to controls [21-25]. The combination of EEG
recording with an experimental design that allows meas-
uring cognitive function is a powerful method to evaluate
cognitive function in controls and patients. In order to
study attentional mechanisms, the so-called Posner para-
digm with central cues has been broadly used [26,27].
In this test, the subject must indicate the location of a tar-
get stimulus. The location of the target stimuli is previ-
ously cued (validly or invalidly) by a central arrow. The
behavioural measures are response times, and percentage
of correct responses, or response errors. There is a benefit
in the RTs if the target stimulus appears in the cued loca-
tion. On the contrary, there is a cost in the RTs if the target
appears in the uncued location.
The results in this paradigm and others have allowed to
propose a theoretical framework about different atten-
tional operations: 1) "disengagement" from the last atten-
tional focus 2) "moving" the attention to the new location
3) "engagement" to the new location [28]. The robustness
of the model has also been tested by different studies
including neuropsychological testing in injured patients,
animal models, neuroimaging and behavioural variables.
All these studies have suggested an attentional neural net-
work including fronto-parietal areas, superior colliculus
and pulvinar nucleus [28]. Moreover, the central cue is
also able to prepare the specific sensory and motor circuits
that are going to be needed to complete the task upon the
available information provided by the central cue[29,30].
The aim of present study was to understand if attentional
mechanism, as measured in the central cue Posner's para-
digm (spatial attention and stimuli discrimination), is
impaired in MS patients. Our hypothesis is that given the
distributed nature of the attentional network, the demy-
elinization process would affect its function in the differ-
ent brain areas of the RRMS patients. Furthermore, the
possibility of testing a group of patients presenting BMS
form would allow to establish the possible cognitive dete-
rioration of these patients, which is not always detected by
neurological and neuropsychological examination, as it
has been suggested by other authors [31]. The analysis of
ERPs component in both groups of MS patients would
help in the definition of the possible cognitive deteriora-
tion of BMS patients.
Results
The RTs of the valid cue condition were statistically signif-
icantly shorter compared to the invalid ones, showing a
facilitated visuo-motor processing when attention is
directed to the validly cued position (F [1, 42] = 37.148, p
< 0.001). This facilitation was present for the Control and
the RRMS group (F [2, 42] = 4.450, p < 0.018), although
the Control group shows a higher difference between
those conditions (34 ms) than the RRMS group (18 ms).Page 2 of 11
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Behavioural resultsFigure 1
Behavioural results. 2A. Response times (RTs) for valid and invalid cues. Notice (i) the shorter RTs in the valid cue with 
respect to invalid cues (except in the BMS group) and, (ii) the shorter RTs in the Control group with respect to the MS groups 
2B. Percentage of Correct Responses (CRs). Notice the low number of hits in the BMS group. CON: Control Group; RRMS: 
relapsing-remitting group; BMS: benign group.
BMC Neuroscience 2006, 7:39 http://www.biomedcentral.com/1471-2202/7/39The BMS group, however, did not show statistically signif-
icant differences between valid and invalid reaction times
(see Figure 1 and Table 1).
The intersubject comparison showed that there was an
effect of the group (F [2, 42] = 14.947, p < 0.001). The
post-hoc analysis showed that the Control group
responded faster than the RRMS group (p < 0.013) and
the BMS group (p < 0.001). Regarding the comparison
between RRMS and BMS groups, RRMS patients were sta-
tistically significantly faster in responding to targets than
the BMS group (p < 0.021) (see Figure 1 and Table 1).
In the inter-subject comparison, the analysis of the per-
centage of correct responses showed that there was an
effect of the group (F [2, 42] = 6.790, p < 0.003). The post-
hoc analysis revealed that this difference was statistically
significant in the comparison between the Control group
and the BMS group (p < 0.002) and between the RRMS
and BMS groups (p < 0.022), and was not statistically sig-
nificant between the RRMS group and the Control (see
Figure 1 and Table 1).
With regard to the analysis of errors, the ANOVA showed
a statistically significant interaction between the effects of
the following factors: cue, type of error and group (F [2,
42] = 4.136; p < 0.020). The interpretation of this result
comes from different evidences. First of all, there were
more errors in the valid cue than in the invalid condition,
and the most frequent type of error was the one termed
"missed". Moreover, this difference was exclusively
present for the BMS group compared to RRMS (p < 0.033)
and Control groups (p < 0.003).
In the analysis of the amplitude of the P1 component,
there was not statistical difference between the different
groups (F [2, 42] = 1.786; p < 0.180). However, the
observed P1 amplitude in the Control and RRMS groups
showed higher amplitude for valid trials compared to
invalid trials, which was not observed in the BMS group.
There was no statistical difference for the P1 latency
between the different groups. With respect to the latency
of the N1 component, the ANOVA showed a statistically
significant effect of the electrode factor (F [3, 42] =
30.226, p < 0.001). The post-hoc analysis showed that the
differences were due to anterior-posterior differences in
latencies (Fz-Oc = p < 0.001; Fz-Pz = p < 0.004; Oc-Cz = p
< 0.001). These differences appeared in both: valid and
invalid. The effect of the group factor was statistically sig-
nificant for the latency of the N1 component (F [2, 42] =
4.259, p < 0.021). The post-hoc analysis revealed that this
difference was due to a statistically significant delayed
latency of the N1 component of the BMS group with
respect to the Control group (p < 0.017) (see Figure 2 and
Table 1).
For the latency of the P300 component, the ANOVA anal-
ysis revealed a statistically significant effect of the group
factor (F [2, 42] = 24.879, p < 0.001). The post-hoc analy-
sis showed that the latency for the Control group (332 ±
23 ms) was faster (p < 0.001) than the latency for both MS
groups (RRMS: 369 ± 28 ms; BMS: 388 ± 38 ms). The post-
hoc analysis also confirmed the statistically signficant dif-
ferences between MS groups (p < 0.042).
The amplitude of the early frontal N1 was clearly different
between the Control group and the MS groups. In fact, the
MS groups presented, at that latency, a positive voltage in
the Fz electrode instead of the negativity observed in con-
trols (Figure 2). The amplitude of the early N1 component
at Fz electrode showed a statistical difference for the effect
of the group factor [F (1, 42) = 6.585; p < 0.003]. The post-
hoc analysis showed a statistical difference between Con-
trol and RRMS groups (p < 0.036) and between Control
compared to BMS group (p < 0.005). There were not sta-
Table 1: Descriptive and Statistical results of the behavioural and ERPs data. CON: Control Group; RRMS: relapsing-remitting group; 
BMS: benign group.
Reaction Times Correct Response % Latency N1 Latency P300 Amplitude N1 frontal
Descriptive Valid Invalid Total Valid Invalid Total Valid Invalid Total Valid Invalid Total Valid Invalid Total
BMS 549 ± 63 560 ± 45 555 ± 51 81 ± 23 79 ± 21 80 ± 23 179 ± 14 179 ± 10 179 ± 12 383 ± 22 386 ± 21 385 ± 21 .97 ± 1.2 .97 ± 2.1 .97 ± 1.6
RRMS 492 ± 47 510 ± 43 501 ± 43 94 ± 05 92 ± 07 93 ± 06 172 ± 13 170 ± 15 171 ± 14 365 ± 19 372 ± 24 368 ± 21 .47 ± .1.2 .33 ± 1.5 .40 ± 1.3
CON 433 ± 50 467 ± 56 450 ± 53 96 ± 04 97 ± 05 96 ± 05 164 ± 12 167 ± 11 165 ± 12 341 ± 15 342 ± 12 341 ± 14 -.85 ± 2.4 -.63 ± .87 -.74 ± 1.6
Anova F p F p F p F p F p
Cue 37.148 <0.001 0.785 0.381 0.001 0.992 1.376 0.258 0.009 0.925
Elec 30.226 <0.001 3.731 0.017
Cue*Group 4.450 0.018 0.575 0.567 0.975 0.386 0.398 0.674 0.151 0.861
Group 14.947 <0.001 6.790 0.003 4.259 0.021 24.879 <0.001 6.685 0.003
Post Hoc RRMS BMS CON RRMS BMS CON RRMS BMS CON RRMS BMS CON RRMS BMS CON
RRMS 0.021 0.013 0.022 0.980 0.287 0.517 0.042 <0.001 0.827 0.036
BMS <0.001 0.002 0.017 <0.001 0.005Page 4 of 11
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groups.
Discussion
The performance in the attentional task was poorer for
BMS group compared to the RRMS group and for both MS
groups with respect to the Control group. This difference
in behaviour was statistically significant and was consist-
ent across all behavioural variables (RTs, errors and per-
centage of correct responses). This difference cannot be
explained by a speed-accuracy trade-off because MS
groups were also less accurate than Control group, partic-
ularly in the case of BMS group. The increase in RTs is a
common result obtained in the MS literature [24,32] and
suggests that BMS patients also show a deterioration in
visuo-motor processing as other subtypes of MS.
ERPs to the standard stimuli in the Fz, Cz, Pz and Oc electrodes for the Control, RRMS and BMS groupsFigure 2
ERPs to the standard stimuli in the Fz, Cz, Pz and Oc electrodes for the Control, RRMS and BMS groups. Notice the delayed 
latency of the P300 (inverted triangle) and posterior N1 (asterisk). Also notice the lack of the early frontal N1 in the BMS and 
RRMS group (the horizontal line indicates the time window used for statistical analysis). CON: Control group; RRMS: relaps-
ing-remitting group; BMS: benign groupPage 5 of 11
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replicate the studies where an improvement of the RTs is
observed for the valid cues compared to the invalid ones
[26,33]. This is explained by the need of a reorienting
mechanism in the invalid condition that it is not neces-
sary for the valid condition. The differences obtained in
the RTs during the Posner paradigm with central cues
indicate that the performance in the spatial attention
processing in the BMS group is impaired, given that there
was not a statistically significant difference between RTs
for valid and invalid cues in the BMS group and the laten-
cies were delayed compared to the Control group. This
impairment could involve both orienting (indicated by
the longer RTs in both conditions for BMS) and reorient-
ing mechanisms (indicated by the lack of statistical signif-
icance between valid and invalid conditions).
The present study reveals that validity effects were
obtained in Control and RRMS groups but were not
obtained in the BMS group. It is possible that the lack of
the validity effect in the BMS group is caused by a pro-
longed duration of the moving and engaging operations,
which would produce a divided attention situation
instead of an oriented spatial attention condition, as it
occurs in the Control and RRMS groups.
To check if these patients were orienting or not to the cue,
we checked if the P1 component showed a change of
amplitude to the stimuli when they were presented in the
validly field with respect to when the cue invalidly cued
the position of the stimulus [34]. The result of this analy-
sis was that although there were not statistically signifi-
cant differences, a higher amplitude was observed for the
validly cued stimulus with respect to the invalidly cued
stimulus in the Control and RRMS groups. However, for
the BMS group, the amplitude of P1 was practically equal
for both conditions, suggesting that it is probable that
these patients carried out a divided attention setting dur-
ing the course of the task.
The analysis of errors yielded a similar conclusion than
the RTs analysis, an increase in the number of errors in the
BMS group with respect to RRMS and controls. The overall
conclusion is that both MS groups showed a behavioural
deterioration compared to controls, but this deterioration
was higher in the BMS group than in the RRMS group.
The latency of the P1 component did not reflect statisti-
cally significant differences among the experimental
groups. These results suggest that the differences found in
the behavioural variables among the diverse groups are
not due to a different processing in the speed of sensory-
visual pathways. One interesting phenomenon appearing
in the ERPs at the same latency than P1 was the inversion
of polarity that occurs in MS patients of the early N1 fron-
tal component. The early N1 frontal component that
appeared in controls has been previously described [35].
They have suggested that this initial volley of information
arrives to the frontal cortex through the dorsal stream and
can be used for an alerting function in the frontal cortex
while more elaborated information arrives from compu-
tation in higher order visual cortex. The patient's inver-
sion of polarity obtained in the N1 frontal component
could be due to a lack of this communication because of
central demyelinization. If the frontal N1 component is
not formed, the posterior P1 could have a much more
frontal extension and produce the inversion of polarity
observed in MS patients in frontal electrodes. A functional
consequence of that would be the lack of the fronto-occip-
ital attentional control that would occur after the frontal
N1 component [35].
The latency of the posterior N1 was increased in the BMS
group with respect to controls. Given the implication of
the N1 in the object discrimination process and its locali-
zation in the occipito-ventral areas [20,29], the increase of
N1 latency in BMS group would implicate a delay in visual
discrimination processes with respect to controls.
On the other hand, we can observe the significant delay in
the latency of the P300 component for MS groups, being
the BMS group the one that exhibited the longest latencies
when compared to the Control group. Indeed, the BMS
group showed statistical differences even with the RRMS
group. Part of this delay is partially due to the N1 latency
delay, at least for the BMS group. This latency delay of the
P3 component has been observed in previous studies with
different pathologies. In the particular case of the multiple
sclerosis, Polich [23] suggested a cognitive deficit associ-
ated to the anomalies in the latency and amplitude of the
P300 component. Ellger [25] presented a significant delay
of the latency of the P300 in different groups of MS,
although the BMS was not studied. Aminof [36] indicated
that the changes in the components of the ERPs in the MS
are due to a central disorder that correlates with the
patient's cognitive state. Dujardin [37] suggested, using
behavioural variables, that the attentional deficit in MS
does not depend on the attentional gain mechanisms.
Instead, the deficit would be caused by the lack of central
resources in the processing of visual information. Our
study reinforces these previous empirical results and sup-
ports the hypothesis that the deficit exhibited is related to
the cognitive processing and not only dependent on sen-
sory processing deterioration.
It is necessary to highlight that in our study, the measures
of P300 peak latency were carried out with standard stim-
uli (that does not require motor response). Therefore, it is
possible to discard any contribution from motor poten-
tials. Moreover, the impaired performance in behaviourPage 6 of 11
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3D scatter-plot that represents RTs, P300 latency and amplitude of the N1 frontal for the different groupsFigure 3
3D scatter-plot that represents RTs, P300 latency and amplitude of the N1 frontal for the different groups. Notice that each 
group occupies a region in the 3D space.
BMC Neuroscience 2006, 7:39 http://www.biomedcentral.com/1471-2202/7/39for the MS patients observed in this study cannot be
explained exclusively in terms of motor dysfunction. The
delay in the P300 component has to be related to a cogni-
tive impairment in the MS patients. It is important to
highlight that the capacity of attentional orientation in
the visual world is a function of enormous importance. It
is not only related to the visuo-attentional process itself,
but it is involved in many processes (e.g.: learning, mem-
ory, etc).
As mentioned above, one of the most surprising results is
the worse execution in the task for what is called benign
course of disease (BMS group). In the clinical practice,
these patients show a slow evolution of the disease with-
out the presence of evident clinical signs for many years
and, therefore, with no pharmacological therapy applied
[1-4,38-40]. However, our test has allowed us to check
that these patients show a poorer behavioural execution
in terms of RTs and errors compared with the RRMS
group. Moreover, the BMS group presented the most
impaired ERPs in both the latencies of the posterior N1
and P300, and in the absence of the frontal N1.
According to those results, it is possible to ask if these
techniques could be useful for diagnostic purposes. The
present results suggest indeed that differences take place
among the different studied groups. However, given the
number of cases studied in our study, it seems daring to
define these measures as diagnostic tools. We believe that
more studies are necessary to confirm the validity of these
parameters in the diagnosis of multiple sclerosis and be
included in future diagnostic criteria.
However, the evidences found in the study suggest that
the behavioural and psychophysiological measures can be
good estimators of the degree of attentional impairment
in multiple sclerosis and help professionals to apply the
appropriate therapeutic measures (see Figure 3).
On the other hand, these results prove that the neurolog-
ical and cognitive evolution of a MS patient does not cor-
relate. In fact, in subjects with a low level of neurological
incapacity (EDSS < 3 or 4), the cognitive profile is
affected. To conclude, these data suggest that the cognitive
impairment in MS could develop in a subtle way during
the course of the disease, producing a deterioration simi-
lar to that experienced by RRMS patients. This fact points
to the necessity of increasing the research in clinical and
laboratory parameters in the prediction and more proper
definition of benign form of multiple sclerosis [31]. These
results confirm that the use of psychophysiological tech-
niques would be recommended to explore the cognitive
profile in multiple sclerosis patients as a complementary
test for the neurological and neuropsychological examina-
tion.
Conclusion
Cognitive deterioration is a highly prevalent symptom
accompanying the general deterioration of MS patients. In
the present experiment, these patients showed an atten-
tional impairment indexed by ERPs and behavioural
responses. The main result was that BMS group presented
a higher deterioration than RRMS group. The latter result
suggests that it could be necessary to follow up the cogni-
tive evolution of the patients with BMS and to consider
therapeutic alternatives to those offered today. Psycho-
physiological techniques combined with specific tasks
(e.g. Posner paradigm) can be helpful in evaluating cogni-
tive impairment in MS.
Methods
Subjects and procedure
Three different groups of subjects participated in the
study: The first group included 17 patients (women 12;
age 38.88 ± 9.04 years old) diagnosed with RRMS without
clear signs of motor impairment, and with a disease dura-
tion of 4.67 ± 4.13 years. The score in Multiple Sclerosis
Expanded Disability Status Scale (EDSS) was 1.6 ± 0.9.
The second group included 10 patients (women 6; age
42.30 ± 7.21 years old) diagnosed with BMS. These
patients had a disease duration of 12.09 ± 4.77 years and
at least 8 years of disease evolution scoring under 3.5 in
the EDSS scale. Diagnosis was made following the criteria
of Poser [1]. The exclusion criteria for the MS groups were:
the presence of a relapse, medication in the last month,
and/or the presence of clear signs of depression. All
patients were clinically stable at baseline (i.e., had no
exacerbations within several months before of study
entry). There were no patients treated with any medica-
tion at the time of evaluation, and only a few presented
history of corticoids treatment in past relapses. Patients
previously assessed at the Multiple Sclerosis Unit of the
Neurology service of the Virgen Macarena Hospital
(Seville, Spain) participated voluntarily in the Psycho-
physiological testing.
The data from both clinical groups were compared with a
group of 18 healthy subjects (women 15; age 36.54 ± 8.73
years old) similar in age, gender proportion and educa-
tional level. The experimental protocol was approved by
the ethical committee of the Hospital. After a full explana-
tion of the nature and general objectives of the experi-
ments, a written consent statement was obtained from
subjects: MS patients and controls.
Experimental protocol
Behavioural responses were recorded during the Posner
paradigm. Five blocks with 200 trials each were presented.
The subjects had 2–3 minutes of rest between blocks. A
trial consisted in a central cue (lasting 300 ms) pointing
to the left or to the right side of the screen, where a targetPage 8 of 11
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response) appears. Targets and standards also lasted 300
ms. Total time for the trial was 1.5 sec and the inter-trial
time was 1 sec. The cue (a white arrow) appeared at the
screen centre. In standards and targets trials the cue could
point to the position where the stimulus appears (valid
trials, 80%) or to the opposite side (invalid trials, 20%)
(see Figure 4). The shape of the target stimuli appearing
randomly at left or right side was a circle with a pattern of
black and red checkerboard subtending a visual angle of
2.46 degrees. The standards presented the same shape
than targets but the colours were changed to black and
white. Subjects had to press the left button of the mouse
with their dominant hand when targets appeared in the
left side, and the right button when the target appeared in
the right side. Therefore, left valid, left invalid, right valid
and right invalid trials appeared for both: standard and
target trials. We decided to use a modified version of the
Posner's paradigm with central cues in which a 75% of
standard stimuli appeared. We chose that proportion in
order to be able to evaluate enough behavioural responses
in the 25 % of target trials, but at the same time, to be able
to analyse cognitive ERPs without motor contamination
during the 75% of standard trials.
The EEG was recorded from 13 electrodes (Fz, Cz, Pz, F3,
F4, C3, F4, P3, F4, T5, F6, O1, O2) from the 10–20 Inter-
national System [41]. The electrodes were referenced to
the left mastoid and re-referenced off-line to the linked
mastoid. Data were filtered using a band-pass of 0.01–100
Hz (1/2 amplitude low- and high-frequency cut-offs); the
amplification gain was 20,000. The EOG was recorded
with bipolar recording by means of electrodes situated in
the external canthi of the ocular orbits and in the inferior
and superior positions of the left orbit. The impedance
was kept under 5 kΩ. EEG was digitised at a frequency rate
of 500 Hz. Artifacts were automatically detected and visu-
ally revised. The trials in which HEOG artefacts higher
than ± 70 µV were detected at electrodes Fz, Cz or Pz, were
rejected. The baseline was 100 ms prior to thestandard
and target stimuli. The different experimental conditions
were averaged independently.
Statistical analysis
The behavioural parameters analysed were Reaction
Times (RTs) to the target stimuli, percentage of correct
responses (CRs) and errors. The considered errors were:
missed when no response to the target occurred, or the
response occurred 700 ms after target stimulus; target error
when responses to the targets occurred with the wrong fin-
ger; and false positive when the response was to standard
stimuli. An ANOVA design for repeated measurements
was used to analyse the RTs and CRs data. The intra-sub-
ject factor was the validity of the cue (two levels: valid vs.
Experimental paradigmFigu e 4
Experimental paradigm.Page 9 of 11
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(three levels: RRMS, BMS and Controls). The Bonferroni
correction was used for post-hoc analysis. In the case of
errors, a mixed factorial ANOVA designed for repeated
measurements was used. The intra-subject factors were:
the validity of the cue (two levels: valid vs. Invalid) and
the classification of errors (misses, target error, and false
positive); the intersubject factor was the subject's group
(three levels: RRMS, BMS and Controls).
Latency was measured for P1, N1 and P300 components.
The P1 latency was obtained as the highest positive deflec-
tion in the time window 90–160 ms for the electrode Oc
(electrode Oc was computed off-line as the mean voltage
of O1 and O2); the N1 component as the highest negative
deflection in the time window 130–210 ms for the elec-
trodes Fz, Cz, Pz and Oc, and the P300 as the highest pos-
itive deflection in the time window 280–400 ms for the
electrodes Fz, Cz and Pz.
The statistical significance of latency differences in the P1
component was tested independently by means of one-
factor ANOVA (three levels: RRMS, BMS and Controls).
To analyse the latency of the N1 and P300 component, a
mixed factorial designed for repeated measurements was
applied to the latency data. For N1 and P300 analysis, the
intra-subject factors were: a) validity of the cue (two lev-
els: Valid and invalid) and b) electrode. The inter-subject
factor was the subject's group (Three levels: RRMS, BMS
and Controls).
Our initial objectives were related to the latency analysis
of ERPs. However, after visual inspection of ERPs in the
midline, an inversion of polarity in the frontal N1 compo-
nent was obvious for the MS groups (see Figure 2). This
highly unexpected result motivated the amplitude analy-
sis of the frontal N1 in the Fz electrode in which a positive
deflection appeared for the MS groups. The mean voltage
between 110 and 130 ms in the electrode Fz was com-
puted in the three subject groups. An ANOVA design for
repeated measurements was used to analyse the ampli-
tude of the frontal N1. The intra-subject factor was the
validity of the cue (two levels: valid vs. Invalid), and the
intersubject factor was the subject's group (three levels:
RRMS, BMS and Controls).
In order to verify the effect of validity in the early phase of
attentional processing, the differences of amplitude for
the P1 component were analysed. The P1 amplitude was
calculated based in a positive deflection which appeared
in the posterior electrodes in all groups. The mean voltage
occurring between 120 and 150 ms in the electrode P3
and P4 was computed in all stimular conditions (left
valid, left invalid, right valid and right invalid trials). An
ANOVA design for repeated measurements was used to
analyse the amplitude of the P1. The intra-subject factors
were: a) validity of the cue (two levels: valid vs. invalid),
b) side of visual field stimulation (two levels: left vs. right)
and c) electrode (two levels: p3 and p4). The intersubject
factor was the subject's group (three levels: RRMS, BMS
and Controls).
Abbreviations
ANOVA analyses of variance
BMS benign multiple sclerosis
CRs correct responses
EDSS expanded disability status scale
EEG electroencephalography
ERPs event-related potentials
MRI Magnetic Resonance Imaging
MS multiple sclerosis
RRMS relapsing-remitting multiple sclerosis
RTs reaction times
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